about
Understanding cognition in older patients with cancerChemotherapy-related cognitive impairment in older patients with cancerDesigning exercise clinical trials for older adults with cancer: Recommendations from 2015 Cancer and Aging Research Group NCI U13 MeetingGeriatric assessment with management in cancer care: Current evidence and potential mechanisms for future researchHigh dose therapy and autologous hematopoietic stem cell transplantation in septuagenarians with non-Hodgkin lymphoma: Feasible, but for which patients?Systematic review of falls in older adults with cancerCost-effectiveness of stereotactic radiation, sublobar resection, and lobectomy for early non-small cell lung cancers in older adultsGaps in nutritional research among older adults with cancerOmission of axillary staging in elderly patients with early stage breast cancer impacts regional control but not survival: A systematic review and meta-analysis.Pragmatic study designs for older adults with cancer: Report from the U13 conference.Trans sectoral care of geriatric cancer patients based on comprehensive geriatric assessment and patient-reported quality of life - Results of a multicenter study to develop and pilot test a patient-centered interdisciplinary care concept for geriatSafety and efficacy of NEPA, an oral fixed combination of netupitant and palonosetron, in older patients.Efficacy of aprepitant among patients aged 65 and over receiving moderately to highly emetogenic chemotherapy: a meta-analysis of unpublished data from previously published studies.A review and assessment of currently available data of the EGFR antibodies in elderly patients with metastatic colorectal cancer.My older patient with cancer reports falls: What should I do?Lymphopenia and clinical outcome of elderly patients treated with sunitinib for metastatic renal cell cancer.Treatment of advanced oesophagogastric cancer with FOLFOX-4 regimen followed by leucovorin/bolus and continuous infusion 5-FU as maintenance chemotherapy in patients aged ≥ 75 years with impaired performance status.Hospital-based health care use correlates with incidence of adverse events among elderly Medicare patients treated in adjuvant chemotherapy trials (Alliance 70802).Health and personal resources in older patients with cancer undergoing chemotherapy.Potential drug interactions and chemotoxicity in older patients with cancer receiving chemotherapy.The Benefit of Adjuvant Chemotherapy in Elderly Patients with Stage III Colorectal Cancer is Independent of Age and Comorbidity.Geriatric Oncology Research in the Cooperative Groups: A Report of a SIOG Special Meeting.Optimal screening for geriatric assessment in older allogeneic hematopoietic cell transplantation candidatesDevelopment and validation of a prognostic index for fracture risk in older men undergoing prostate cancer treatment.Functional status declines among cancer survivors: trajectory and contributing factors.Participation and survival of geriatric patients in Phase I clinical trials: the Karmanos Cancer Institute (KCI) experienceEffects of yoga on cancer-related fatigue and global side-effect burden in older cancer survivors.Phase I Clinical Trials in Patients ≥80Tolerability and efficacy of docetaxel in older men with metastatic castrate-resistant prostate cancer (mCRPC) in the TAX 327 trial.TREATMENT AND SURVIVAL PATTERNS IN RELATION TO MULTIMORBIDITY IN PATIENTS WITH LOCOREGIONAL BREAST AND COLORECTAL CANCERPain is prevalent and persisting in cancer survivors: differential factors across age groups.Do age and quality of life of patients with cancer influence quality of life of the caregiver?Screening older cancer patients for a Comprehensive Geriatric Assessment: A comparison of three instruments.Survival and selected outcomes of older adults with locally advanced head/neck cancer treated with chemoradiation therapy.The effects of age, education, and treatment on physical, sexual and body concern symptoms among multimorbid, colorectal cancer survivors.Guideline-concordant lung cancer care and associated health outcomes among elderly patients in the United States.The prevalence of potentially modifiable functional deficits and the subsequent use of occupational and physical therapy by older adults with cancer.Predictors of chemotherapy dose reduction at first cycle in patients age 65 years and older with solid tumors.Does Life Expectancy Affect Treatment of Women Aged 80 and Older with Early Stage Breast Cancers?Metabolic syndrome and colorectal cancer: is hyperinsulinemia/insulin receptor-mediated angiogenesis a critical process?
P1433
Q26747296-5486DBE0-2AFB-43C1-AD82-2190060389E8Q26747612-3ADE0E30-6DE9-47F7-B767-D9FB8955405EQ26747628-C410412D-E31A-41CA-92CC-312E04BE360AQ26747632-827ACBA8-59C0-48D7-BB77-13D28C11F217Q26852501-E011EF40-890D-4068-AE99-766B4D149406Q26853317-26EF27D4-5B2B-42AE-B1DD-869709F86CF1Q27309908-4224E07D-E067-4AAC-B330-9C1C74D433FEQ28067552-B3734CE1-5A7B-46D3-B218-4A483474E3EAQ30240031-D7566422-665F-4EA6-B771-EC21FFDB0084Q30250266-E71CB6CC-8EF4-42E9-A3FA-3DCC0AA47E57Q30313154-A20E1CDC-BAF1-4133-A754-6211546CD66BQ30313662-4C324633-A0F2-43C3-BE2A-FE786780773BQ30670337-41DC0E9E-4163-44F5-AB9C-C526A71BA65CQ31047943-FD402A5C-85AB-4A85-A5EC-3C1C74DB1BA5Q33166361-F01A0FF1-5C9C-4D78-9F2F-7C675909B1C4Q33413133-859EE32B-8499-4700-B715-A65DE6ABD453Q33424849-421EDE50-9714-4796-B390-B87F37060804Q33992552-C7AD4096-FF8C-4AAE-8119-F0066BCA7E95Q34073694-0BFD8B15-228A-47ED-889B-39B8BF9D3309Q34130767-AFE13424-FB76-4B2B-8522-22CD7D29361BQ34339987-2DF48C87-4536-4FB2-B7B3-6170C2AC29CAQ34460029-8E4AA2AC-2D87-46A4-8CF1-5C90E6ABD42BQ34514273-3E780B65-3C7B-4D4F-AC7F-FC3120D2D332Q34615270-64ED34EB-A8EB-42C5-ADED-F4D50DA8DA9BQ34623432-CE18F58E-E02F-4049-AA96-E632E1DAE1F8Q34801461-499ECE49-5C1C-401B-9162-0F565EB9A59AQ34980359-B1A55B32-CE16-4843-BFC9-3501CA79B2AFQ34990971-6C911F0F-E706-4BA7-B18E-9B00881DAA8FQ35086832-22E45C60-12FE-47DA-9780-C476F2821674Q35117528-ECAC4E5D-9B5D-4BE1-8F74-95DB8E73773FQ35162653-5DC7F9B6-0D73-4954-91F5-1A70D5F6CD53Q35191022-20045B4B-DE24-4305-AA9F-D1A78D11A2E0Q35214123-313E8824-67C1-483A-83E9-8535D1358D64Q35551059-A6C8BFD2-C966-4788-9CC0-4985E8504351Q35616950-F14ABBE3-7D42-4CD6-ABC8-376D8926C27DQ35668438-36A3D525-0208-49BD-AB5D-8A40666EAE65Q35695779-530519AD-911E-4C09-9AC3-B89161C4EC5FQ35771257-DFCE5E9D-0927-45D6-ABDA-1186449C8E4AQ35773188-B840AF34-FE89-4ECD-9CD5-54177FDD006AQ35923538-D77AD1AE-6AAB-47C0-A3A5-447A079B3CB8
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Elsevier
@nl
wissenschaftliche Fachzeitschrift
@de
name
Journal of Geriatric Oncology
@ast
Journal of Geriatric Oncology
@en
Journal of Geriatric Oncology
@es
Journal of Geriatric Oncology
@it
Journal of Geriatric Oncology
@nl
type
label
Journal of Geriatric Oncology
@ast
Journal of Geriatric Oncology
@en
Journal of Geriatric Oncology
@es
Journal of Geriatric Oncology
@it
Journal of Geriatric Oncology
@nl
prefLabel
Journal of Geriatric Oncology
@ast
Journal of Geriatric Oncology
@en
Journal of Geriatric Oncology
@es
Journal of Geriatric Oncology
@it
Journal of Geriatric Oncology
@nl
P31
P3181
P1055
P1058
P1156
19700175259
P123
P1250
P1277
P1476
Journal of Geriatric Oncology
@en